Mechanism Study on the Treatment of Pelvic Pain in Endometriosis by Qu Yu Jie Du Xiao Zheng Decotion in Combination with Dextroprogesterone

In: MEDS Basic Medicine · 2023 · vol. 1(3) · doi:10.23977/medbm.2023.010304 · W4390653698
article OA: hybrid CC0

Abstract

This study aimed to evaluate the clinical efficacy and effect on serum levels of PGE2, NGF and TNF-α of the combination of Qu Yu Jie Du Xiao Zheng Decotion and Dydrogesterone in treating pelvic pain in patients with endometriosis. Sixty patients were randomly divided into three groups: Chinese medicine group, Western medicine group, and combination group. After treatment, the combination group showed significant relief of pain, and the apparent efficacy of menstrual pain, pelvic pressure pain, and palpable nodules was 70%, 83.33%, and 61.54%, respectively, which was significantly higher than that of the other two groups. There were significant differences in serum TNF-α, NGF and PGE2 levels among the three groups after treatment. The conclusion was that the combination of Qu Yu Jie Du Xiao Zheng Decotion and Dydrogesterone could significantly improve the immune function of patients with endometriosis, regulate levels of nerve growth factor, tumor necrosis factor, and prostaglandin E2, thereby relieving pain.
Full text 27,290 characters · extracted from oa-pdf · 4 sections · click to expand

Keywords

Endometriosis, Qu Yu Jie Du Xiao Zheng Decotion, Deferiprone, Tumor Necrosis Factor, Prostaglandins, Nerve Growth Factor

Abstract

This study aimed to evaluate the clinical efficacy and effect on serum levels of PGE2, NGF and TNF -α of the combination of Qu Yu Jie Du Xiao Zheng Decotion and Dydrogesterone in treating pelvic pain in patients with endometriosis . Sixty patients were randomly divided into three groups: Chinese medicine group, Western medicine group, and combination group. After treatment, the combination group showed significant relief of pain, and the apparent efficacy of menstrual pain, pelvic pressure pain, and palpable nodules was 70%, 83.33%, and 61.54%, respectively, which was significantly higher than that of the other two groups. There were significant differences in serum TNF-α, NGF and PGE2 levels among the three groups after treatment. The conclusion was that the combination of Qu Yu Jie Du Xiao Zheng Decotion and Dydrogesterone could significantly improve the immune function of patients with endometriosis , regulate levels of nerve growth factor, tumor necrosis factor, and prostaglandin E2, thereby relieving pain. 1. Introduction Endometriosis (EMs) is a gynecological disease caused by endometrial growth in the uterus and other extra-uterine parts, which mostly occurs in women aged 20-45 years old, and the incidence of this disease has been on the rise in recent years [1].EMs can infiltrate other organs in the patient's pelvic cavity, and has the characteristics of proliferation, hyperplasia, and metastasis, with clinical manifestations such as pelvic pain and infertility, which seriously affect the patient's health and quality of life [2].For the treatment of EMs, Western medicine mainly adopts sex hormone therapies such as progesterone, contraceptive pills, and mifepristone to achieve the purpose of relieving pain by inhibiting ovulation, which has a better effect on symptomatic improvement in the short term, but is prone to drug resistance, and the symptoms are easy to recur after discontinuing the drug [3].In Chinese medicine, this disease belongs to the category of "dysmenorrhea" and "symptoms". In recent years, many scholars believe that the pathogenesis of EMs is stasis of blood, evil blood congestion in the uterus and veins of the uterus, which becomes toxic over time and is transformed into stasis of toxins, and advocate that this disease should be treated with the method of eliminating MEDS Basic Medicine (2023) Clausius Scientific Press, Canada DOI: 10.23977/medbm.2023.010214 ISSN 2616-2091 Vol. 1 Num. 2 89 stasis of blood and removing toxins [4]. In the present study, in order to enhance the efficacy of EMs, the treatment of Qu Yu Jie Du Xiao Zheng decotion was added on the basis of conventional western medicine treatment, which is now reported as follows. 2. Information and Methods In this study, a total of sixty patients diagnosed with EMs were selected from the gynecology outpatient clinic of Xi'an Hospital of Traditional Chinese Medicine between January 2022 and December 2022. The random assignment of patients to different treatment groups, namely A: Traditional Chinese medicine group, B: Western medicine group, and C: Combination of Chinese and Western medicine group, was conducted using the random number generation algorithm in SPSS22.0 statistical software. The age range of the traditional Chinese medicine group was between 25 and 44 years, with an average age of 33.95± 4.23 years. The duration of the disease varied from 0.4 to 5 years, with an average duration of 2.07± 1.15 years. The body mass index ranged from 19.8 to 26, with a mean body mass index of 22.28± 1.34. In the western medicine group, the age range was between 22 and 25 years, with a mean age of 32.55± 6.75 years. The disease d uration varied from 0.5 to 4 years, with an average duration of 1.85± 1.18 years. The body mass index ranged from 18.9 to 27, with a mean body mass index of 22.72± 1.95. In the group combining Chinese and Western medicines, the age range was between 25 and 45 years, with a mean age of 33.5± 5.63 years. The disease duration varied from 1 to 6 years, with an average duration of 2.35± 1.31 years. The body mass index ranged from 19 to 26, with a mean body mass index of 22.32± 1.49. After conducting a χ2 test, the di fference between the baseline data of the three groups was not statistically significant (P>0.05), and was considered comparable. The inclusion criteria for this study were as follows: ① Patients with endometriosis who met both the clinical diagnostic crit eria of Western medicine [5] and the Chinese medicine diagnosis of "stasis, toxicity, dampness and turbidity" [6]; ② Patients who did not have plans for pregnancy within the next year; ③ Patients who voluntarily agreed to participate in the study and signe d the informed consent form; ④ Patients who had previously undergone treatment with hormonal drugs or conservative surgical treatments, and had ceased usage for a minimum of three months; or patients who had received traditional Chinese medicine (TCM) trea tment for at least three months; or patients who had previously received TCM treatment, but had stopped using the medicine for at least one month and still met the aforementioned diagnostic criteria. The exclusion criteria for this study encompass various medical conditions, which include severe uterine fibroids, cardiovascular and cerebrovascular diseases, hepatic and renal diseases, as well as hematopoietic system diseases. Additionally, patients with psychiatric disorders and those who have demonstrated allergies to the drug being tested, as well as the control drug, are also excluded. Furthermore, individuals who fail to meet the inclusion criteria, fail to adhere to the drug usage criteria, or have incomplete data that may hinder the assessment of thera peutic efficacy and safety are also excluded. Treatment ① The oral Qu Yu Jie Du Xiao Zheng decoction in the Traditional Chinese medicine group consists of various herbal ingredients. These include 30g of Sargentgloryvine Stem , 30g of Hedyotis diffusa, 30g of Coix seed, 30g of Astragalus membranaceus, 15g of Corrugated wood, 15g of Litchi seed (broken), 10g of Pseudobulbus Cremastrae seu Pleiones (broken), 9g of Agastache rugosus (after the lower part of the head), 2 Centipede (with head and feet removed), 6g of Resina draconis, 6g of Eupolyphaga, 6g of Olibanum, 6g of Myrrha, and 6g of Radix Glycyrrhizae Preparata[7]. The Xi'an Hospital of Traditional Chinese Medicine's Pharmacy Center prepared a decoction, while the Traditional Chinese Medicine Decoction R oom provided the broth, in the amount of 200mL per bag. The recommended dosage is one bag, two times a day, in the morning 90 and evening. It is important to note that no other medications should be taken for this condition during the treatment period. Additi onally, the consumption of cold drinks, oily foods, and stimulating foods should be minimized while taking this medication. If a cold is contracted, the medication should be immediately discontinued. In the event of pregnancy during treatment, the medication should also be stopped immediately. Individuals with allergies to Chinese medicine are prohibited from using this medication, and those who are allergic should exercise caution. ② Western medicine group: Daflon (Diflucan tablets Abbott Biologicals B.V . (Netherlands)) should be administered at a dosage of 10mg per intake, twice daily, starting from the fifth day of the menstrual cycle and continuing for a duration of 20 days. It is necessary to undergo a consecutive treatment regimen for three menstrual cy cles. It is important to note that the concomitant use of other medications with similar effects is strictly contraindicated during the treatment period. ③ Combination of Chinese and Western medicines group: the administration method of oral Chinese medicine is similar to that of the Chinese medicine group. Additionally, dydrogesterone tablets are orally administered starting on the 5th day of menstruation, following the dosage and administration

Method

of the Western medicine group. There is no combined me dication involved.Observation indicators Pelvic pain scores: The "Pelvic Pain Assessment Scale" [8] was utilized by patients to document various aspects of their pain. These included menstrual pain, encompassing abdominal and breast pain, as well as lumba r pain before and after menstruation, and symptoms of anal irritation during menstruation. Additionally, scores were assigned to other pelvic pain symptoms, such as non -menstrual pelvic pain, pain during intercourse, and anal cramps. The severity of menstr ual pain and non-menstrual pelvic pain was measured using the Visual Analog Scale (V AS) before and after treatment for all three patient groups. Serum factor levels: ELISA was used to detect the levels of nerve growth factor (NGF), prostaglandin E2 (PGE2) and tumor necrosis factor -alpha (TNF-α) in the peripheral blood in the serum before and after treatment, and the experimental process was carried out in strict accordance with the instructions. In this experiment, percent efficacy was used to assess the tr eatment effect. The formula for calculating the percentage of efficacy was (pre -treatment points - post-treatment points)/pre-treatment points)× 100%. According to the calculated percentage of efficacy, the efficacy was categorized into four grades: cured, obvious, effective and ineffective. The specific efficacy evaluation criteria are as follows: ① Cured: after drug intervention, various clinical symptoms disappeared, such as pelvic masses, tender nodules and other local signs basically disappeared. The percentage of efficacy (N) is greater than or equal to 95% [9]. ② Significant effect: clinical symptoms basically disappeared and pelvic mass was reduced (compared with gynecological examination and pelvic ultrasound examination at the same time of menstrual cycle). The percentage of efficacy is 95% greater than N greater than or equal to 70%. ③ Effective: Symptoms are relieved and pelvic lesions are not significantly enlarged or slightly reduced. The percentage of efficacy is 70% greater than N greater than or equal to 30%. Ineffective: no change or aggravation of the main symptoms, local lesions have a tendency to aggravate. The percentage of efficacy (N) is less than 30%. According to the above criteria, patients can be categorized into different levels a ccording to the efficacy percentage to assess the effectiveness of treatment. Statistical methods In this experiment, SPSS 22.0 statistical software was used to process the obtained data. For the general data of the three groups of patients, the chi -square test was used to analyze the count data, while for the measurement data, the variance chi -square test was performed first, and then the independent samples t -test was used to compare the differences between the 91 groups, while the paired samples t -test was used to compare the differences between the groups. When the p-value is less than 0.05, it means that the difference is statistically significant. 3. Results 3.1 Comparison of VAS Scores among the 3 Groups See Table 1. Table 1 . Comparison of VAS scores in 3 groups (x± s, points) Group Number of cases Before treatment After treatment Before and after difference (D value) Chinese medicine group 20 5.83± 1.95 2.8± 1.05 3.03± 1.55 Western medicine group 20 5.60± 2.14 3.05± 1.36 2.55± 1.75 Chinese and Western medicine Combined group 20 6.10± 1.80 1.95± 1.05 4.15± 1.43 As can be seen from Table 1, the V AS scores of the three groups had different decreases after treatment. After t -test, the difference between the points of the combined Chinese and Western medicine group compared with the Chinese medicine group and the Western medicine group was extremely significant (p the difference of the Chinese medicine group > the difference of the Western medicine group, which indicated that in terms of the effect of pain relief, the combined Chinese and Western medicine group had a better effect than the other two groups. 3 .2 Comparison of Pelvic Pain Efficacy after Treatment in the 3 Gr oups See Table 2. Table 2. Comparison of the effective rate of pelvic pain treatment among 3 groups of patients Symptoms Group Number of cases Disappearance rate Menstrual abdominal pain Chinese medicine group 19 9 (47.36%) Western medicine group 17 7 (41.11%) Chinese and Western medicine Combined group 20 14(70.00%) Lumbosacral pain Chinese medicine group 15 7 (46.67%) Western medicine group 18 8 (44.44%) Chinese and Western medicine Combined group 15 10(66.67%) Pelvic pressure pain Chinese medicine group 18 10(55.56%) Western medicine group 19 9(47.37%) Chinese and Western medicine Combined group 18 15(83.33%) Sexual intercourse pain Chinese medicine group 11 7(63.64%) Western medicine group 14 8(57.14%) Chinese and Western medicine Combined group 12 10(83.30%) Anal pain Chinese medicine group 13 8(61.54%) Western medicine group 11 6(54.55%) Chinese and Western medicine Combined group 14 11(78.57%) Tender nodules Chinese medicine group 12 5(41.67%) Western medicine group 15 7(46.67%) Chinese and Western medicine Combined group 13 8(61.54%) 92 As can be seen from Table 2, after treatment, the apparent efficacy rates of menstrual abdominal pain, pelvic pressure pain, and tender nodules of the patients in the combination of Chinese and Western medicines group were 70%, 83.33%, and 61.54%, respectively, which were higher than those of the rest of the two groups, and the difference between the apparent efficacy rates of pelvic pain of the combination of Chinese and Western medicines treatment group compared with the Chinese medicine treatment group and the Western medicine treatment group was extremely significant after the χ2 test (p<0.01); after treatment, the apparent efficacy rates of intercourse pain, lumbosacral pain, anal pain of patients in the After the treatment, the apparent efficiency of sexual intercourse pain, lumbosacral cramps and anal cramps of the patients in the combined group was also higher than that of the remaining two groups, but the difference was not statistically significant, which indicated that the combination of traditional Chinese and Western medicines group could achieve effective relief of pelvic pain. 3.3 Comparison of Serum TNF-α, NGF and PGE2 Levels before and after Treatment in the 3 Groups See Table 3. Table 3. Comparison of serum TNF-α, NG F and PGE2 levels before and after treatment in 3 groups of patients As shown in the above table, the difference in serum TNF- α, NGF and PGE2 levels between the three groups before and after treatment was statistically significant (p < 0.05 or p < 0.01), in addition, the difference in TNF- α, NGF and PGE2 levels after treatment between the weste rn medicine group and the combination of western and traditional Chinese medicines group was statistically significant (p < 0.05), and the difference between the Chinese and western medicine group after treatment TNF- α, NGF and PGE2 levels after treatment in the Chinese medicine group and the combination of Chinese and Western medicines group, the difference was statistically significant (P < 0.05), while the difference was not statistically significant in the comparison of TNF-α, NGF and PGE2 levels after treatment in the Chinese medicine group and the combination of Chinese and Western medicines group (P > 0.05). Item Chinese medicine group (n=20) Western medicine group (n=20) Chinese and Western medicine Combined group(n=20) F value P value TNF-α Before treatment 11.94± 1.33 11.86± 2.54 11.52± 1.96 0.268 0.767 Post-treat ment 10.54± 1.75 9.15± 3.58 7.87± 3.30 3.416 0.038 NGF Before treatment 89.97± 9.39 80.81± 17.31 90.62± 10.60 2.140 0.134 Post-treat ment 72.15± 12.56 66.23± 14.06 64.07± 26.40 4.901 0.014 PGE2 Before treatment 95.318± 8.790 95.01± 12.77 98.04± 9.43 0.307 0.738 Post-treat ment 81.620± 15.33 79.87± 18.07 63.51± 26.68 6.453 0.004 93 4. Discussion Effect of Qu Yu Jie Du Xiao Zheng decotion in Combination with Dydrogesterone Tablets on Pelvic Pain The results of this study showed that after the intervention of Qu Yu Jie Du Xiao Zheng decotion in Combination with Dydrogesterone Tablets, the patients' pelvic pain was significantly improved, and the significant scores of dysmenorrhea, pelvic tenderness and palpable nodules were higher than those of dysmenorrhea, pelvic pain, and palpable nodules of the rest of the two groups with a statistically significant difference (P<0.05), which confirms that Qu Yu Jie Du X iao Zheng decotion can also effectively relieve other symptoms such as pain during sexual intercourse and anal pain. Effects of Qu Yu Jie Du Xiao Zheng decotion in combination with Difluprednate Tablets on the levels of TNF -α, NGF and PGE2 in the serum of the patients Modern medicine believes that endometriosis is a kind of intractable disease, and the mechanism of its pathogenesis is extremely complex, which has not been completely clarified, and is currently dominated by the retrograde flow of menstrual blood and the implantation theory [10], that is, the fragments of the endometrium retrograde flow of menstrual blood and enter the pelvic cavity via the fallopian tubes, and then are planted in the ovary or other parts of the pelvic cavity [11]. or other pa rts of the pelvis [11]. Pelvic pain is one of the main symptoms of endometriosis, and the mechanism by which it arises is a complex process. Studies have shown that immunoinflammatory factors, estrogen levels, nerve growth factors, and serum prostaglandins are closely related to the occurrence of endometriosis-related pain. It has been found that ectopic endothelial tissue can secrete nerve growth factor (NGF) [12], and activated macrophages can produce a large amount of tumor necrosis factor (TNF-) and increase the level of cyclooxygenase-2 (COX2), which in turn increases the level of prostaglandins, which in turn increases the level of prostaglandins. The activated mast cells can degranulate and secrete TNF - and PGs [13]. Therefore, the serum levels of TNF -, NGF and PGE2 are higher in patients with endografts. According to the results of this experiment, the levels of TNF-α, NGF and PGE2 in the serum of patients in the combined Chinese and Western medicine group were significantly lower after treatment comp ared with those before treatment, and the difference was statistically significant (P < 0.01). Meanwhile, there were significant differences between the Western medicine group and the combined Chinese and Western medicine group in the levels of TNF -α, NGF and PGE2 after treatment (P < 0.05). Significant differences also existed between the TCM group and the combined TCM and Western medicine group in the levels of TNF-α, NGF and PGE2 after treatment (P 0.05). This suggests that the combination of Qu Yu Jie Du Xiao Zheng decotion and Difenocoumarol Tablets was able to regulate the le vels of TNF -α, NGF and PGE2 in the serum of the patients, which significantly alleviated the pain of pelvic pain in patients with endogamy. Legislative basis for the treatment of endometriosis byQu Yu Jie Du Xiao Zheng decotion in combination with dextroprogesterone tablets Endometriosis is an estrogen -dependent disease, for which Western medicine drug therapy is mainly given as hormonal thera pies (progestins, birth control pills, sex hormones such as mifepristone). Deferiprogesterone is a progestin, which can inhibit endometrial hyperplasia, shrink the ectopic endometrium, and further inhibit the development of ectopic foci [14]. Endometriosis belongs to the category of "dysmenorrhea" and "obstruction in the abdomen" in traditional Chinese medicine (TCM). TCM believes that the core of this disease is "blood stasis", so the treatment is based on activating blood circulation and eliminating blood stasis. In recent years, some scholars believe that the basic pathology of EMs is not only "blood stasis", but also "turbid fluid", and that both of them can not only be brewed into 94 stasis toxin and dampness toxin for a long period of time, but also fumigate with each other and turn into heat toxin. In the previous project, we have formulated Qu Yu Jie Du Xiao Zheng decotion, which has the function of dispelling blood stasis, resolving toxins and removing turbidities, and eliminating crushing and dispersin g lumps and knots, to treat dysmenorrhea and obstruction in the abdomen of internal heterotaxy, and it has achieved good therapeutic effect. In this experiment, in order to improve the efficacy of EMS, the formula of Qu Yu Jie Du Xiao Zheng decotion was added on the basis of oral administration of dydrogesterone tablets, in which all the medicines in the formula were combined together to eliminate and remit the evil toxins in an all -rounded way and at various levels, such as clearing away heat and detoxific ation, dispelling blood stasis, removing dampness and resolving turbidities and toxins, clearing up the channels of the worms and eliminating the toxicity and alleviating the toxicity by benefiting the qi to support the toxins and relieving toxicity throug h the glycytes and the toxins, so as to eliminate blood stasis and clear up channels of the worms and resolving turbidities and eliminating symptoms and alleviating pain [15]. The results of this study also proved that the difference in V AS scores before a nd after treatment between Qu Yu Jie Du Xiao Zheng decotion in combination with dydrogesterone tablets was more obvious compared with the traditional Chinese medicine group and the western medicine group (P<0.05), and the improvement of pelvic pain in the combination of traditional Chinese medicine and western medicine group was more significant than that in the rest of the two groups, which suggests that the addition of Qu Yu Jie Du Xiao Zheng decotion in combination with dydrogesterone tablets can enhance the effect of improving pelvic pain. The difference in serum TNF-α, NGF and PGE2 levels between the Chinese and Western medicine combination group before and after treatment was statistically significant (P < 0.01), confirming that the combination of Qu Yu Jie Du Xiao Zheng decotion and dydrogesterone tablets could regulate the serum levels of TNF-α, NGF and PGE2 in patients with endogenous syndrome. In conclusion, the combination of Qu Yu Jie Du Xiao Zheng decotion with dydrogesterone tablets can regulate the serum levels of TNF-α, NGF and PGE2 in patients, effectively improve the symptoms of pelvic pain in patients with endometriosis, and the effect is remarkable, which provides a new way of thinking for the treatment of endometriosis pain. Funding Health Research Talent Program of Xi'an Municipal Health Planning Commission (2022yb02)

References

[1] Sun A’ mei, Liu Changyun, Liu Hanrong, Wang Zhengfang. Effects of tonifying kidney and eliminating stasis formula combined with danazol on serum estrogen/progesterone and prostaglandin in patients with endometriosis. World TCM,2018,013(3):683-686690. [2] Wang Manli, Wang Wei. Study on the efficacy of endometriosis treatment with endoisolation formula combined with conservative surgery and goserelin. Chinese Journal of Traditional Chinese Medicine,2016,34(06):1354-1356.DOI:10.13193/j.issn.1673-7717.2016.06.020. [3] Sun Mengzhu, Huang Wenqing. Progress of research on pathogenesis and clinical diagnosis and treatment of endometriosis. International Journal of Laboratory Medicine,2023,44(16):2017-2022. [4] Zhang Xiaofeng, Zhang Mingliang. Effect ofQu Yu Jie Du Xiao Zheng decotion on the levels of IL-6 and IL-8 in the peritoneal fluid of rats with endometriosis. Shaanxi Traditional Chinese Medicine,2013,34(12):1676-1678. [5] Zhang Su. Guidelines for combined diagnosis and treatment of endometriosis with Chinese and Western medicine. Chinese Journal of Integrative Medicine and Western Medicine,2019,39(10):1169-1176. [6] Zhang Xiaofeng, Wang Qing. A preliminary study on the treatment of endometriosis from the theory of "stasis, dampness, turbidity and toxicity interconnecting and damaging the collaterals". Shaanxi Traditional Chinese Medicine,2014,35(3):338-340. [7] Zhang Xiaofeng, Dong Oriyun, Wang Qing. Treatment of 45 cases of endometriosis by Qu Yu Jie Du Xiao Zheng decotion. Shaanxi Traditional Chinese Medicine,2009,30(3):260-261. 95 [8] Mao Haiyan, Chen Yuanhuan, Wu Qunsheng et al. The effect of Jiawei Shaobuyu Tang on neuroangiogenesis of pelvic pain in endometriosis with cold-congealed blood stasis. Chinese Journal of Experimental Formulas,2022,28(12):141-147.DOI:10.13422/j.cnki.syfjx.20221295. [9] Fan Qiong, Wei Yuna, Yin Ling, et al. Clinical observation on the treatment of endometriosis pelvic pain with qi stagnation and blood stasis by rhubarb. Chinese Journal of Experimental Formulas, 2019, 25(12):6. DOI:10.13422/j.cnki.syfjx.20191231. [10] Zhang Wei, Lu Jianjun. Effects of Liver-Sparing, Blood-Nourishing and Collaterals Formula combined with mifepristone on pain level and serum PGE_2,PGF_(2α),NGF levels in endometriosis dysmenorrhea patients. Journal of Modern Integrative Medicine, 2019, 28(32):5. DOI:CNKI:SUN:XDJH.0.2019-32-011. [11] Shi Shujing, Xiang Mei, Song Wenling et al. A case of large omental endometrioid cyst combined with plasma cystadenoma. International Journal of Obstetrics and Gynecology,2014,41(03):330-331+333. [12]Liu Lina. Study on the relationship between endometrial nerve fiber distribution and endometriosis pain. Dalian Medical University,2012. [13] Dimitrijevic D, Vasiljevic M, Anicic R, et al. Recurrence rate of ovarian endometriosis in patients treated with laparoscopic surgery and postoperative suppressive therapy. Clin Exp Obstet Gynecol,2015,42(3):339-343. [14] Chang Fengge, Sun Lingxia, Ma Yuyao. Efficacy of two drugs combined with hysteroscopic electrodesiccation for the treatment of early stage endometrial cancer respectively and the effect on reproductive function. Cancer Progress, 2020, 18(1):4. DOI:CNKI:SUN:AZJZ.0.2020-01-013. [15] Hui Xuelian. Clinical research on the treatment of endometriosis by expelling blood stasis, detoxifying and eliminating symptoms of endometriosis soup. Shaanxi College of Traditional Chinese Medicine [2023-12-11].DOI:10.7666/d.y1658354. 96

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK